The results showed SRXN1 expression was higher in separate subgroups of HCC patients compared with a healthy population, which indicated the high expression of SRXN1 was universal in HCC regardless of gender, age, race, stage, and grade (Figure 2). This evidence concerns the gene SRXN1 and hepatocellular carcinoma.